TABLE 2
Overview of Radionuclides, Peptides, and Antibodies
Radionuclide
n
177
Lu-CPCR4
6 (24%)
90
Y-CPCR4
11 (44%)
90
Y-CPCR4 +
188
Re-CD66
6 (24%)
90
Y-CPCR4 +
90
Y-ibritumomab tiuxetan
1 (4%)
90
Y-CPCR4 +
153
Sm-EDTMP
1 (4%)